$AMRZ

Billionaire Leon Cooperman Says Investors Are Acting Like ‘Pavlov’s Dog’ — Reveals 2 New Stock Picks

Leon Cooperman expressed a negative market view due to rising fiscal deficit and debt, citing Warren Buffett's analogy of investors acting like 'Pavlov's dogs'. Omega Advisors, managed by Cooperman, revealed new positions in Amrize AG (AMRZ) and GPGI (GPGI). Amrize reported Q2 revenue growth but missed EBITDA expectations, with RBC downgrading the stock to underperform. Management expects pricing to align with costs by Q4.

Original reporting
Published Aug 24, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 4:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Billionaire Leon Cooperman Says Investors Are Acting Like ‘Pavlov’s Dog’ — Reveals 2 New Stock Picks — source image
Decision brief

The 30-second read

$AMRZBullishLow
01

Why it matters

Fund purchases introduce new institutional demand but are modest relative to market size.

02

Market read

The story adds a small, new data point on institutional buying for AMRZ and GPGI.

03

What to watch

RBC downgrade and margin compression could offset fund support.

Relevance 4/10Novelty 3/10Timing: none

Background

Leon Cooperman comments on market sentiment; article shifts to Omega Advisors' Q2 fund holdings.

Company-level read

Ticker impact

$AMRZBullishMedium confidence
Context

Omega Advisors disclosed buying 880,000 shares of AMRZ in its Q2 filing.

Expected impact

Modest upside potential as institutional demand appears.

Evidence & confidence

New institutional ownership can signal confidence but size is modest.

$GPGIBullishMedium confidence
Context

Omega Advisors disclosed buying 11.38 million shares of GPGI in its Q2 filing.

Expected impact

Potential short-term rally on fresh demand.

Evidence & confidence

Significant share count indicates strong interest from a known investor.

Market effects

Highlights continued interest in building‑materials and diversified industrial sectors.

No immediate regional effect beyond U.S. equities.

Limited to investors tracking fund activity.

Counterpoint

Fund buying may be premature if margins continue to pressure AMRZ.

Key entities

  • Leon Cooperman

    Billionaire investor providing market commentary.

  • Omega Advisors

    Asset manager reporting new Q2 holdings.

Related articles

High

BofA downgrades Amrize to underperform, cuts price target on slower growth outlook

Bank of America downgraded Amrize to Underperform, cutting its price target to $40 from $50 due to slower earnings growth, market risks, and valuation concerns. The brokerage lowered its 2027-28 adjusted EBITDA and EPS estimates, citing stable U.S. cement prices, Canadian demand pressure from U.S. tariffs, and vulnerable roofing margins. BofA forecasts adjusted EBITDA growth of 3% and adjusted EPS growth of 6% annually over 2026-28, excluding large acquisitions. The bank also trimmed its buildin

$AMRZMed

BofA downgrades Amrize stock on growth concerns, cuts price target to $40

BofA Securities downgraded Amrize Ltd (NYSE:AMRZ) to Underperform, cutting its price target to $40 from $50. The stock is near its 52-week low, down 20% YTD. BofA reduced 2027-28 EBITDA estimates by 3%, citing growth concerns, U.S. cement price stability, and Canada macro risks. Amrize's Q2 earnings missed estimates, though revenue beat forecasts. Other analysts also downgraded the stock due to earnings misses and management changes.

High

Why is Amrize stock sliding today?

Amrize AG (AMRZ) fell 2.9% to CHF 34.13 after JPMorgan downgraded it to Neutral, citing executive departures and missed earnings. The stock hit a 52-week low of CHF 33.64, with JPMorgan lowering its price target to $52 from $57. The broader market showed no significant movement, indicating the decline is company-specific.